AC Immune SA
ACIU
$1.68
$0.0150.90%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -21.17M | -17.99M | 6.36M | -25.17M | -20.43M |
| Total Depreciation and Amortization | 680.80K | 602.40K | 611.60K | 606.00K | 635.90K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.11M | -1.32M | -1.35M | 10.16M | 249.30K |
| Change in Net Operating Assets | -2.55M | 25.46M | -21.98M | 95.16M | 20.72M |
| Cash from Operations | -20.93M | 6.76M | -16.35M | 80.76M | 1.17M |
| Capital Expenditure | -402.70K | -102.50K | -195.40K | -75.20K | -284.80K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 3.77M | -4.25M | -2.22M | -83.77M | -26.66M |
| Cash from Investing | 3.37M | -4.36M | -2.41M | -83.84M | -26.95M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -253.00K | -171.00K | -172.00K | -173.00K | -167.00K |
| Issuance of Common Stock | -- | -- | -- | 135.00K | 2.00K |
| Repurchase of Common Stock | -- | -25.00K | -1.00K | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -5.00K | -1.00K | 0.00 | -24.00K | -523.00K |
| Cash from Financing | -287.00K | -224.30K | -200.00K | -68.60K | -786.90K |
| Foreign Exchange rate Adjustments | -299.20K | 2.22M | -3.17M | -2.87M | 1.99M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -18.15M | 4.39M | -22.14M | -6.02M | -24.57M |